One-year survival ( % ) and median survival ( months ) were as follows : standard radiation therapy -- 46 % , 11.4 months ; chemotherapy plus radiotherapy -- 60 % , 13.8 months ; and hyperfractionated radiation therapy -- 51 % , 12.3 months .
